HAPLN1 and Miyoshi myopathy: Nevertheless, HAPLN1-PTR1 was unable to cause apoptosis resistance to carfilzomib in any of the MM cell lines tested even though it did so against bortezomib and ixazomib in almost all cell lines tested.